Global Bone Morphogentic Protien Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 – 2023

Global Bone Morphogentic Protien Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 – 2023

  • May 2017 •
  • 140 pages •
  • Report ID: 4927548
Bones morphogenetic proteins (BMP) are set of proteins originate from human body. Bone morphogenetic proteins are responsible for the growth and play significant role in the maintenance, repair and regulation of bone formation. Bone morphogenetic method helps in the formation of new bones and in the process bone harvesting. BMP products increase the demand of bone morphogenetic market as it reduces healing time. The bone morphogenetic proteins market is growing with fast pace due to rising sports and road accidents injuries. The rising number of people who are suffering from spinal injuries together with a rise in surgical rate are primary drivers for the market. According to National spinal cord injury statistical center, approx 314 million people in the U.S. are suffering from spinal cord injury in 2016.

The global bone morphogenetic protein market has enormous opportunity to increase its demand in emerging countries. The major challenge is lack of professionals in the field of bone morphogenetic protein market, hampering the BMP market growth.The global bone morphogenetic proteins market is segmented on the basis of type and application. On the basis of type, the global bone morphogenetic protein market is sub divided into recombinant bone morphogenetic protein-7 (rhBMP-7) and recombinant bone morphogenetic protein-2 (rhBMP-2). On the basis of application, the bone morphogenetic proteins market id sub divided into oral maxillofacial surgery, spinal fusion, reconstructive and trauma. Spinal fusion segment shows the largest market share globally due to various factors such as increasing demand for minimally invasive medical procedures, rise in sports injuries, rise in spinal injuries and growing in geriatric population etc.

Geographically, the global bone morphogenetic protein market is bifurcated into North America, Europe, Asia Pacific and Rest of the world. North America is the leading region for the bone morphogenetic protein market followed by Europe. Factors driving demand of bone morphogenetic market are awareness of protein product, adoption of new technology by orthopedic surgeons, increase in geriatric population, prevalence of unhealthy lifestyle and increase in the incidence of spinal injuries. According to National Spinal Cord Injury Statistical Center approx 314 million people are suffering from spinal cord injury in U.S. 2016.

Some of the key players in the bone morphogenetic protein market are ProSpec; DePuySynthes; Medtronic; R&D Systems; Cellumed Co. Ltd.; Sigma-Aldrich Corporation; and Ember Therapeutics Inc. These companies are using various strategies such as merger, joint venture, acquisition, partnership and product launching to sustain in the market.